-
RE-LY randomized 18,113 patients to one of its three arms. In the entire study group, dabigatran 110 mg twice per day compared with warfarin was associated with lower risks of major bleeding (2.87% vs 3.57 %), intracranial bleeding (0.23% vs 0.76%), and life-threatening bleeding (1.24% vs 1.85%).
-
In this paper, Haines and his coauthors propose a scoring system to predict risks associated with implantable cardioverterdefibrillator (ICD) implant procedures.
-
Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions.
-
The authors conclude that even short-term treatment with most NSAIDs was associated with increased risk of death and recurrent MI in patients with prior MI. Neither short- nor long-term treatment with NSAIDs is advised in this population, and any NSAID use should be limited from a cardiovascular safety point of view.
-
The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) study showed that in patients with stable coronary artery disease (CAD) put on optimal medical therapy (OMT) that randomization to a percutaneous coronary intervention did not improve survival or prevent myocardial infarction.
-
-
-
Erectile dysfunction (ED) is the most common sexual problem in men, affecting up to one-third at some point in their lives.
-
-
Having just glanced in the refrigerator and realized that, yet again, a week had passed and I had forgotten to take my omega-3 capsules, I wondered what I could do to develop a daily routine that would foster my good health. I am not alone in these musings and frustrations; patients recount to me daily that "Sorry, doc, Ive been bad, or I forgot to take my pills last night. Im sure thats why my blood pressure is up."
